Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Receivables - Net (2009 - 2025)

Grifols' (GIFLF) quarterly Receivables - Net came in at $757.8 million in Q4 2025, up 0.59% on a YoY basis from $753.4 million in Q4 2024, and up 0.59% quarter-over-quarter from $753.4 million in Q4 2024.

Analysis

Grifols (GIFLF) Receivables - Net (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Receivables - Net for 17 consecutive years, with $757.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 0.59% year-over-year to $757.8 million; the trailing twelve-month figure through Dec 2025 stood at $757.8 million (up 0.59% YoY), and the FY2025 full-year result was $735.5 million, down 7.17% from the prior year.
  • Receivables - Net rose to $757.8 million in Q4 2025 per GIFLF's latest filing, from $753.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $757.8 million in Q4 2025 and bottomed at -$26.9 million in Q4 2023.
  • Historically, Receivables - Net has averaged $520.5 million across 5 years, with a median of $621.4 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Receivables - Net plunged 104.33% in 2023, then surged 2900.75% in 2024.
  • Over 5 years, Receivables - Net stood at $496.6 million in 2021, then gained by 25.12% to $621.4 million in 2022, then slumped by 104.33% to -$26.9 million in 2023, then soared by 2900.75% to $753.4 million in 2024, then rose by 0.59% to $757.8 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods registered $757.8 million, $753.4 million, and -$26.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 757.79 Mn
Dec 31, 2024 753.36 Mn
Dec 31, 2023 -26.90 Mn
Dec 31, 2022 621.41 Mn
Dec 31, 2021 496.64 Mn
Dec 31, 2020 456.92 Mn
Sep 30, 2020 663.81 Mn
Mar 31, 2020 560.38 Mn
Dec 31, 2019 409.32 Mn
Sep 30, 2019 516.62 Mn
Mar 31, 2019 678.24 Mn
Dec 31, 2018 307.23 Mn
Sep 30, 2018 538.34 Mn
Jun 30, 2018 366.66 Mn
Mar 31, 2018 496.64 Mn
Dec 31, 2017 336.98 Mn
Jun 30, 2017 363.19 Mn
Dec 31, 2016 446.63 Mn
Sep 30, 2016 425.36 Mn
Jun 30, 2016 491.01 Mn